Cover of Next

Next by Michael Crichton

A Novel

By Michael Crichton

3.8out of 5

Editorial score · Worth reading with reservations

Next is a messy, often funny biotech mosaic whose best legal and scientific provocations never quite become one satisfying novel.

Best forReaders interested in biotechnology, patents, genetic privacy, satire, and idea density more than unified character drama.

See current formats on Amazon

As an Amazon Associate, I earn from qualifying purchases.

Pace
Brisk
Darkness
Moderate
Romance
Minimal
Difficulty
Accessible

Should you read Next?

What works

Gene ownership, tissue rights, patents, transgenic animals, research incentives, and family identity intersect through cases that expose real ethical absurdities.

What may not work for you

The many storylines produce tonal whiplash, some characters are satirical sketches, and convergence feels engineered rather than inevitable.

What may test your patience

Frequent jumps among lawsuits, laboratories, families, and talking animals delay attachment to any central arc.

Does the ending reward the effort?

Several threads close neatly, but the cumulative argument remains a dossier of concerns rather than a fully integrated payoff.

Reading Next closely

Next uses an ensemble of scientists, families, lawyers, companies, and transgenic animals rather than one continuous protagonist. Gene patents, tissue ownership, research fraud, commercialization, and unusual hybrids intersect as biotechnology companies claim rights over biological material that remains part of living people.

The fragmented structure resembles a set of escalating case studies connected by theme. A talking parrot and a humanlike transgenic chimp provide satire and emotional focus, while legal and corporate episodes ask whether existing property rules can govern inheritance, identity, and reproduction. Some threads are deliberately absurd; others draw on recognizable disputes.

Readers expecting the focused suspense of Jurassic Park may find the many switches disruptive. The novel works better as a dark biotech panorama, energetic and argumentative rather than tightly unified. Its specific legal and genetic references have aged, but the questions about data, consent, and ownership remain relevant whenever innovation moves faster than public rules.

A network rather than one hero

Separate plots demonstrate different consequences of treating genes as information and property.

Transgenic lives

The animals are not merely inventions; their intelligence exposes the moral limits of ownership.

Law follows the laboratory

Courts and companies apply old categories to biological relationships those categories were not designed to handle.

Edition published
Review
Published
Reviewed by
Leon Bossasi
Genres & moods
Science FictionThriller

Three useful comparisons

Prey

Michael Crichton

Prey is a tighter survival thriller centered on one runaway technology.

Best for: Pick it for nanotechnology, emergent systems, laboratory isolation, corporate secrecy, and fast survival suspense.

Read review →
View on Amazon

As an Amazon Associate, I earn from qualifying purchases.

The Terminal Man

Michael Crichton

The Terminal Man examines medical intervention through one precise tragic case.

Best for: Readers interested in neuroscience, medical ethics, behavioral control, and concise technothrillers.

Read review →
View on Amazon

As an Amazon Associate, I earn from qualifying purchases.

Micro

Michael Crichton

Micro returns to a linear corporate-science adventure with more natural history and physical danger.

Best for: Go here for science adventure, miniaturized survival, Hawaiian ecology, body danger, and rapid set pieces.

Read review →
View on Amazon

As an Amazon Associate, I earn from qualifying purchases.

Reader rating

Reader scores are kept separate from my editorial rating above.

Reader average: No reader ratings yet. Be the first to rate it.

Your rating

Choose a star to leave your own rating.